Related Experiment Videos
The GABA(A) receptor complex as a target for fluoxetine action
G Tunnicliff1, N L Schindler, G J Crites
1Department of Biochemistry, Indiana University School of Medicine, Evansville 47712, USA. gtunnic@iupui.edu
Neurochemical Research
|September 24, 1999
Summary
Fluoxetine, an antidepressant, also affects GABA(A) receptors. This study shows fluoxetine can inhibit GABA binding and alter chloride uptake, potentially explaining its antidepressant effects.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Fluoxetine is a widely used antidepressant known as a selective serotonin reuptake inhibitor.
- The GABA(A) receptor complex is a key target in the central nervous system involved in inhibitory neurotransmission.
Purpose of the Study:
- To investigate the interaction of fluoxetine with the GABA(A) receptor complex.
- To explore the potential role of GABA(A) receptor modulation in fluoxetine's antidepressant mechanism.
Main Methods:
- Radioligand binding assays were used to assess fluoxetine's effect on [3H]GABA and [3H]flunitrazepam binding to GABA(A) receptors.
- GABA-stimulated chloride uptake assays in rat cerebral cortical vesicular preparations were performed to evaluate functional effects.
Main Results:
- Fluoxetine inhibited the binding of [3H]GABA and [3H]flunitrazepam to the GABA(A) receptor complex in a concentration-dependent manner (IC50 values of 2 mM and 132 microM, respectively).
- Low concentrations of fluoxetine (1 nM) enhanced GABA-stimulated chloride uptake, while higher concentrations (100 microM and 1 mM) inhibited it by reducing Emax.
Conclusions:
- Fluoxetine interacts with the GABA(A) receptor complex beyond its known action on serotonin reuptake.
- These findings suggest that modulation of GABA(A) receptor function may contribute to the antidepressant effects of fluoxetine.